Old Web
English
Sign In
Acemap
>
authorDetail
>
Fuminari Yamaguchi
Fuminari Yamaguchi
Takeda Pharmaceutical Company
Angiotensin II
Oral administration
Angiotensin receptor
Azilsartan Medoxomil
Azilsartan
2
Papers
37
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models
2011
European Journal of Pharmacology
Keiji Kusumoto
Hideki Igata
Mami Ojima
Ayako Tsuboi
Mitsuaki Imanishi
Fuminari Yamaguchi
Hiroki Sakamoto
Takanobu Kuroita
Naohiro Kawaguchi
Nobuhiro Nishigaki
Hideaki Nagaya
Show All
Source
Cite
Save
Citations (37)
Mittel zur verbesserung der insulinresistenz
2002
Kiminori c
o Mitsubishi Pharma Corp. Kawahara
Keiji Kusumoto
Haruto c
o Mitsubishi Pharma Corp. Nakagawa
Hiroki C
o Mitsubishi Pharma Corp. Tamakawa
Zen-ichi Terashita
Fuminari Yamaguchi
Show All
Source
Cite
Save
Citations (0)
1